China-Based Porton Fine Chemicals Opens Technology Center In Cranbury, New Jersey
10/05/2016
According to the firm, “this new venture will serve the US biopharmaceutical industry, offering drug development and cross-lifecycle research, development and manufacturing solutions from a strategic location convenient to East Coast and West Coast-based companies."
Company officials said they choose the location because it is conveniently located off the NJ Turnpike [I-95] near many of the world's largest pharmaceutical companies in New Jersey, and with easy flight access to the innovation hotbeds of Boston and California; PTC can be reached in 45 minutes by road from Newark International Airport.
Featuring state of the art assets and experienced process scientists, engineers, analysts and support staff, PTC aims to deliver innovative solutions and compelling value on complex synthetic routes, next-generation processes and assembly of specialized molecules, officials explained.
Today's pharmaceutical company pipelines are dominated by complex molecules, posing formidable synthesis, scale-up and containment challenges, company experts said. According to Dr. John Dillon, Senior Vice President of Porton Fine Chemicals and President of PortonUSA, ADCs exemplify a "Perfect Storm" of manufacturing difficulties: unstable APIs and toxic intermediates requiring high containment, complex analytics, purifications and parenteral requirements.
"We see high demand for this type of niche process development and manufacturing as companies seek innovative external manufacturing partners who can bring considerable experience to reliably execute such projects, many of which involve single batches representing >$1 million in value,” he said.
"Building on our excellent track record and feedback from our customers, PTC is a key element of our global strategy to offer advanced technologies, diversify our service offerings, and enhance our engagement with customers from close proximity, ultimately helping them more efficiently meet their drug development and commercialization goals. It will also complement our new Shuitu Technology Center [Chongqing, China] to be opened by end-2016," Drs. Andrew Xu, President/Co-Chairman of PFC and Raj Iyer, Chief Business Officer, PFC explained.
"Leveraging the critical mass of experienced process chemists in this region and integrating PTC's CRO capabilities with PFC's manufacturing expertise centered in a lower cost geography such as China will offer powerful end-to-end solutions and seamless supply chains to the biopharmaceutical community," according to Dr. Todd Nelson, Vice President, Porton USA and General Manager, PTC.
Project Announcements
Kimberly-Clark Expands Aiken County, South Carolina, Distribution Operations
05/04/2025
Aerowerks Plans Gaffney, South Carolina, Manufacturing Operations
05/04/2025
Sweden-Based Troax Group Plans Portland, Tennessee, Manufacturing Operations
05/04/2025
Kimberly-Clark Corporation Plans Warren, Ohio, Manufacturing Operations
05/04/2025
Denmark-Based Novonesis Expands Salem, Virginia, Production Operations
05/04/2025
Polyvlies USA Expands Winston-Salem, North Carolina, Manufacturing Operations
05/04/2025
Most Read
-
Run a Job Task Analysis
Q4 2024
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
The Location Economics of Advanced Nuclear
Q1 2025
-
Why Workforce Readiness Can’t Wait
Q1 2025
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Is It Time to Start Planning for Quantum Data Centers?
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024